Gen9 is the premier next-generation gene synthesis company focused on high-quality, high-throughput, automated production of DNA constructs. Currently, Gen9 offers multiple synthetic biology solutions for researchers who need high quality clonal, sequence-perfect DNA. Our award winning BioFab® process is remarkably flexible and very high throughput; allowing us to make the genes you need quickly at the highest quality available. Gen9 is Powering the Synthetic Biology Revolution.
Gen9 total Funding
Gen9 latest funding size
Time since last funding
|4 years ago|
|Agilent Technologies, Draper Fisher Jurvetson (DFJ)|
Gen9 has 2.85k Twitter Followers. The number of followers has decreased 0.1% month over month and decreased 0.4% quarter over quarter